No OSA (AHI <5 events·h−1) | Mild OSA (AHI 5– <15 events·h−1) | Moderate-to-severe OSA (AHI ≥15 events·h−1) | ||||
OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
Subjects | 1096 (50.81) | 700 (32.45) | 361 (16.74) | |||
aTAC (≥100 units) | ||||||
Lower EFV tertile (T1) | Reference | 1.04 (0.72–1.51) | 0.83 | 1.14 (0.76–1.72) | 0.54 | |
Middle EFV tertile (T2) | 0.87 (0.55–1.35) | 0.53 | 1.35 (0.89–2.04) | 0.16 | 1.46 (0.96–2.23) | 0.08 |
Upper EFV tertile (T3) | 1.01 (0.54–1.92) | 0.97 | 1.86 (1.14–3.05) | 0.01 | 2.11 (1.30–3.43) | 0.003 |
dTAC (≥100 units) | ||||||
Lower EFV tertile (T1) | Reference | 0.75 (0.52–1.08) | 0.12 | 1.08 (0.73–1.62) | 0.70 | |
Middle EFV tertile (T2) | 0.98 (0.64–1.50) | 0.93 | 1.59 (1.06–2.37) | 0.02 | 1.22 (0.80–1.85) | 0.36 |
Upper EFV tertile (T3) | 1.37 (0.73–2.58) | 0.33 | 1.51 (0.92–2.49) | 0.11 | 1.38 (0.84–2.26) | 0.21 |
TAC (≥400 units) | ||||||
Lower EFV tertile (T1) | Reference | 0.63 (0.42–0.94) | 0.02 | 0.89 (0.58–1.38) | 0.60 | |
Middle EFV tertile (T2) | 0.76 (0.48–1.22) | 0.43 | 1.19 (0.77–1.83) | 0.43 | 1.13 (0.73–1.75) | 0.60 |
Upper EFV tertile (T3) | 0.99 (0.51–1.92) | 0.97 | 1.41 (0.84–2.36) | 0.20 | 1.29 (0.77–2.14) | 0.33 |
CAC (>0 units) | ||||||
Lower EFV tertile (T1) | Reference | 1.27 (0.87–1.84) | 0.21 | 1.35 (0.89–2.04) | 0.16 | |
Middle EFV tertile (T2) | 0.83 (0.52–1.31) | 0.42 | 0.98 (0.63–1.53) | 0.94 | 1.19 (0.77–1.83) | 0.43 |
Upper EFV tertile (T3) | 1.62 (0.88–2.98) | 0.12 | 1.17 (0.71–1.95) | 0.54 | 1.29 (0.79–2.10) | 0.32 |
Data for numbers of subjects are presented as n (%). AHI: apnoea–hypopnoea index; aTAC: ascending TAC; dTAC: descending TAC. The logistic regression analysis was adjusted for age, sex, body mass index, hypertension, type 2 diabetes, high-density lipoprotein cholesterol, how-density lipoprotein cholesterol and pack-years of smoking.